CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node StageMarkus Eckstein, Sven Wach, Elena Epple et al.|Cancers|2020Cited by 30
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In VivoSven Wach, Achim Aigner, Anna Peters et al.|Molecular Therapy — Nucleic Acids|2019Cited by 30
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant ChemotherapyHelge Täubert, Sven Wach, Markus Eckstein et al.|Cells|2021Cited by 27
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patientsMarkus Eckstein, Helge Täubert, Rudolf Jung et al.|Scientific Reports|2018Cited by 24
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic<i>TMPRSS2:ERG</i>fusion statusManuel Luedeke, Christiane Maier, Antje E. Rinckleb et al.|Human Molecular Genetics|2016Cited by 12